Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

3.14
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
1.20
Today|||52-Week Range
4.54
+102.58%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues175.0K382.0K158.3K31.4M
 
 
 
 
 
Depreciation And Amortization1.3M2.3M3.3M4.7M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses47.5M82.0M82.5M63.7M
 
 
 
 
 
Research And Development23.1M47.3M41.5M31.7M
 
 
 
 
 
Total Operating Expenses48.8M84.3M85.7M68.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-48.6M-83.9M-85.6M-37.0M
 
 
 
 
 
Extraordinary Credit--2.9M5.9M2.2M
 
 
 
 
Extraordinary Charge-10.7M-12.0M-2.4M0.00
 
 
 
 
Pre-Tax Equity Earnings-78.9K0.000.000.00
 
 
Other Expenses23.2K437.1K57.4K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-58.7M-91.9M-81.7M-34.4M
 
 
 
 
 
Income Taxes-5.3K-2.4K-2.4K-2.4K
 
 
 
 
 
Minority Interest-95.2K0.000.000.00
 
 
Net Income-58.6M-91.9M-81.7M-34.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS46.9M57.4M61.1M73.9M
 
 
 
 
 
Shares To Calculate EPS Diluted46.9M57.4M61.1M73.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.25-$1.60-$1.34-$0.47
 
 
 
 
 
EPS Diluted-$1.25-$1.60-$1.34-$0.47